The human immunodeficiency virus type 1 (HIV-1)vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules

Journal of Experimental Medicine

Volumn 185, Issue 7, 1997, Pages 1295-1305

  Kerkau, Thomas ^a   Bacik, Igor ^b   Bennink, Jack R ^b   Yewdell, Jonathan W ^b   Hünig, Thomas ^a   Schimpl, Anneliese ^a   Schubert, Ulrich ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS PROTEIN;

ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

CD8-POSITIVE T-LYMPHOCYTES; DOWN-REGULATION; GENE PRODUCTS, VPU; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV-1; HUMANS; IMMEDIATE-EARLY PROTEINS; RECOMBINANT PROTEINS; VACCINIA VIRUS;

EID: 0030940154     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.7.1295     Document Type: Article

References (75)

1. Townsend, A., C. Öhlén, J. Bastin, H.-G. Ljunggren, L. Foster, and K. Kärre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature (Lond.). 340:443-448.
2. Yewdell, J.W., and J.R. Bennink. 1992. Cell biology of antigen processing and presentation to MHC class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1-23.
3. Heemels, M.-T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463-491.
4. Peters, J.M. 1994. Proteasomes: protein degradation machines of the cell. TIBS (Trends Biochem. Sci.). 19:377-382.
5. Niedermann, G., S. Butz, H.G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschützky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity. 2:289-299.
6. Spies, T., V. Cerundolo, M. Colonna, P. Cresswell, A. Townsend, and R. DeMars. 1992. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature (Lond.). 355:644-646.
7. Higgins, C.F. 1995. The ABC of channel regulation. Cell. 82:693-696.
8. Townsend, A., and J. Trowsdale. 1993. The transporter associated with antigen presentation. Semin. Cell Biol. 4:53-61.
9. Maudsley, D.J., and J.D. Pound. 1991. Modulation of MHC antigen expression by viruses and oncogenes. Immunol. Today. 12:429-431.
10. McFadden, G., and K. Kane. 1994. How DNA viruses perturb MHC expression to alter immune recognition. Adv. Cancer Res. 63:117-209.
11. Howcroft, T.K., K. Strebel, M.A. Martin, and D.S. Singer. 1993. Repression of MHC class I gene promotor activity by two-exon Tat of HIV. Science (Wash. DC). 260:1320-1322.
12. Burgert, H.-G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell. 41:987-997.
13. Yamashita, Y., K. Shimokata, S. Saga, S. Mizuno, T. Tsurumi, and Y. Nishiyama. 1994. Rapid degradation of the heavy chain of class I major histocompatibility complex antigens in the endoplasmic reticulum of human cytomegalovirus-infected cells. J. Biol. 68:7933-7943.
14. Beersma, M.F.C., M.J.E. Bijlmakers, and H.L. Ploegh. 1993. Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains. J. Immunol. 151:4455-4464.
15. Wiertz, E.J.H.J., T.R. Jones, L. Sun, M. Bogyo, H.J. Geuze, and H.L. Ploegh. 1996. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell. 84:769-779.
16. 8+ T lymphocytes. Cell. 77:525-535.
17. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature (Lond.). 375: 411-415.
18. Früh, K., K. Ahn, H. Djaballah, P. Sempe, P.M. van Endert, R. Tampe, P.A. Peterson, and Y. Yang. 1995. A viral inhibitor of peptide transporters for antigen presentation. Nature (Lond.). 375:415-418.
19. + T cell line, CEM-E5, after HIV-1 infection. J. Immunol. 143:2858-2866.
20. Kerkau, T., R. Schmitt-Landgraf, A. Schimpl, and E. Wecker. 1989. Downregulation of HLA class I antigens in HIV-1-infected cells. AIDS Res. Hum. Retroviruses. 5:613-620.
21. Kerkau, T., S. Gernert, C. Kneitz, and A. Schimpl. 1992. Mechanism of MHC class I downregulation in HIV infected cells. Immunobiology. 184:402-409.
22. Bevan, M.J., and T.J. Braciale. 1993. Why can't cytotoxic T cells handle HIV? Proc. Natl. Acad. Sci. USA. 92:5763-5767.
23. Matsui, M., R.J. Warburton, P.C. Cogswell, A.S. Baldwin, Jr., and J.A. Frelinger. 1996. Effects of HIV-1 Tat on expression of HLA class I molecules. J. Acquired Immune Defic. Syndr. 11:233-240.
24. Strebel, K., T. Klimkait, and M.A. Martin. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science (Wash. DC). 241:1221-1223.
25. Strebel, K., T. Klimkait, F. Maldarelli, and M.A. Martin. 1989. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J. Virol. 63:3784-3791.
26. Cohen, E.A., E.F. Terwilliger, J.G. Sodroski, and W.A. Haseltine. 1988. Identification of a protein encoded by the vpu gene of HIV-1. Nature (Lond.). 334:532-534.
27. Maldarelli, F., M.Y. Chen, R.L. Willey, and K. Strebel. 1993. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type 1 integral membrane protein. J. Virol. 67: 5056-5061.
28. Schubert, U., T. Schneider, P. Henklein, K. Hoffmann, E. Berthold, H. Hauser, G. Pauli, and T. Porstmann. 1992. Human-immunodeficiency-virus-type-1-encoded Vpu protein is phosphorylated by casein kinase II. Eur. J .Biochem. 204: 875-883.
29. 56 within a predicted α-helix-turn-α-helix-motif. J. Mol. Biol. 236:16-25.
30. Huet, T., R. Cheynier, A. Meyerhans, G. Roelants, and S. Wain-Hobson. 1990. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature (Lond.). 345:356-359.
31. Klimkait, T., K. Strebel, M.D. Hoggan, M.A. Martin, and J.M. Orenstein. 1990. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64:621-629.
32. Terwilliger, E.F., E.A. Cohen, Y. Lu, J.G. Sodroski, and W. A. Haseltine. 1989. Functional role of human immunodeficiency virus type 1 vpu. Proc. Natl. Acad. Sci. USA. 86: 5163-5167.
33. Schubert, U., K.A. Clouse, and K. Strebel. 1995. Augmenttion of virus secretion by the HIV-1 Vpu protein is cell-type-independent and occurs in cultured human primary macrophages and lymphocytes. J. Virol. 69:7699-7711.
34. Travers, K., S. Mboup, R. Marlink, A. Guèye-Ndiaye, T. Siby, I. Thior, I. Traore, A. Dieng-Sarr, J.L. Sankalé, C. Mullins et al. 1995. Natural protection against HIV-1 infection provided by HIV-2. Science (Wash. DC). 268:1612-1615.
35. Marlink, R., P. Kanki, I. Thior, K. Travers, G. Eisen, T. Siby, I. Traore, C.C. Hsieh, M. Ciré Dia, E.H. Gueye et al. 1994. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science (Wash. DC). 265: 1587-1590.
36. Li, T.J., M. Halloran, C.I. Lord, A. Watson, J. Ranchalis, M. Fung, N.L. Letvin, and J.G. Sodroski. 1995. Persistent infection of Macaques with Simian-Human Immunodeficiency Viruses. J. Virol. 69:7061-7071.
37. Aldrovandi, G.M., and J.A. Zack. 1996. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice. J. Virol. 70:1505-1511.
38. Willey, R.L., F. Maldarelli, M.A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66:226-234.
39. Willey, R.L., F. Maldarelli, M.A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 vpu protein induces rapid degradation of CD4. J. Virol. 66:7193-7200.
40. Buonocore, L., and J.K. Rose. 1990. Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature (Lond.). 345:625-628.
41. Popovic, M., M.G. Sarngadharan, E. Read, and R.C. Gallo. 1984. Detection, isolation, and continous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science (Wash. DC). 224:497-500.
42. Ratner, L., W. Haseltine, R. Patarca, K.J. Livak, B. Starcich, S.F. Josephs, E.R. Doran, J.A. Rafalski, E.A. Whitehorn, K. Baumeister et al. 1985. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature (Lond.). 313:277-284.
43. Adachi, A., H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
44. Schubert, U., and K. Strebel. 1994. Differential activities of the human immunodeficiency virus type-1 encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:2260-2271.
45. Folks, T., S. Benn, A. Rabson, T. Theodore, D. Hoggan, M.A. Martin, M. Lightfoot, and K. Sell. 1985. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus. Proc. Natl. Acad. Sci. USA. 8:4539-4543.
46. Schubert, U., S. Bour, A.F. Ferrer-Montiel, M. Montal, and K. Strebel. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:809-819.
47. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
48. Eisenlohr, L.C., I. Bacik, J.R. Bennink, K. Bernstein, and J.W. Yewdell. 1992. Expression of a membrane protease enhances presentation of endogenous antigens to MHC class I-restricted T lymphocytes. Cell. 71:963-972.
49. Banks, T.A., F.J. Jernkins, S. Nair, S. Dasgupta, C.M. Foster, and B.T. Rouse. 1994. Vaccination with the immediate-early protein ICP47 of herpes simplex virus type 1 (HSV1) induces virus-specific lymphoproliferation, but fails to protect against lethal challenge. Virology. 200:236-245.
50. Bacik, I., J.H. Cox, R. Anderson, J.W. Yewdell, and J.R. Bennink. 1994. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino-but not carboxyl-terminus of the peptide. J. Immunol. 152:381-387.
51. Broder, C.C., D.S. Dimitrov, R. Blumenthal, and E.A. Berger. 1993. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology. 193:483-491.
52. Siu, G., S.M. Hedrick, and A.A. Brain. 1989. Isolation of the murine intercellular adhesion molecule 1 (ICAM-1) gene. ICAM-1 enhances antigen-specific T cell activation. J. Immunol. 143:3813-3820.
53. Yuwen, H., J.H. Cox, J.W. Yewdell, J.R. Bennink, and B. Moss. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology. 195:732-744.
54. Smith, M.H., J.M.R. Parker, R.S. Hodges, and B.H. Barber. 1986. The preparation and characterization of anti-peptide heteroantisera recognizing subregions of the intracytoplasmic domain of class I H-2 antigens. Mol. Immunol. 23:1077-1092.
55. Deen, K.C., J.S. McDougal, R. Inacker, G. Folena-Wasserman, J. Arthos, J. Rosenberg, P. Maddon, J.R. Axel, and R.W. Sweet. 1988. A soluble form of CD4 (T4) protein inhibits AIDS virus infection. Nature (Lond.). 331:82-84.
56. Federau, T., U. Schubert, J. Floßdorf, P. Henklein, D. Schomburg, and V. Wray. 1996. Solution structure of the cytoplasmic domain of the human immunodeficiency virus type 1 encoded virus protein U (Vpu). Int. J. Pept. Protein Res. 47: 297-310.
57. Schwartz, O., V. Maréchal, S. Le Gall, F. Lemonnier, and J.-M. Heard. 1996. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Mad. 2:338-342.
58. Arthur, L.A., J.W. Bess, Jr., R.C. Sowder II, R.E. Benveniste, D.L. Mann, J.-C. Chermann, and L.E. Henderson. 1992. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science (Wash. DC). 258:1935-1938.
59. Hasenkrug, K.J., J.M. Kory, and J.H. Stimpfling. 1987. Monoclonal antibodies defining mouse tissue antigens encoded by the H-2 region. Immunogenetics. 25:136-139.
60. Song, E.S., Y. Yang, M.R. Jackson, and P.A. Peterson. 1994. In vivo regulation of the assembly and intracellular transport of class I major histocompatibility complex molecules. J. Biol. Chem. 269:7024-7029.
61. Ahn, K., T.H. Meyer, S. Uebel, P. Sempé, H. Djaballah, Y. Yang, P.A. Peterson, K. Früh, and R. Tampé. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47. 1996. EMBO (Eur. Mol. Biol. Organ.) J. 15:3247-3255.
62. Tomazin, R., A.B. Hill, P. Jugovic, I. York, P. van Endert, H.L. Ploegh, D.W. Andrews, and D.C. Johnson. 1996. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO (Eur. Mol. Biol. Organ.) J. 15:3256-3266.
63. Koup, R.A., J.T. Safrit, Y. Cao, C.A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D.D. Ho. 1994. Temporal association of cellular immune response with the initial control of viremia in primary human immunodeficiency type 1 syndrome. J. Virol. 68:4650-4655.
64. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature (Lond.). 370:463-467.
65. Moss, P.A.H., S.L. Rowland-Jones, P.M. Frodsham, S. McAdam, P. Giangrande, A.J. McMichael, and J.I. Bell. 1995. Persistent high frequency of human immunodeficiency virus-specific cytotoxic T cells in peripheral blood of infected donors. Proc. Natl. Acad. Sci. USA. 92:5773-5777.
66. Koup, R.A. 1995. Virus escape from CTL recognition. J. Exp. Med. 180:779-782.
67. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J.-P. Levy, J.-G. Guillet, and S. Saragosti. 1994. Impaired CTL recognition due to genetic variations in the main immunogenic region of the HIV-1 NEF protein. J. Exp. Med. 180:1129-1134.
68. Meier, U-C, P. Klenerman, P. Griffin, W. James, B. Köppe, B. Larder, A. McMichael, and R. Phillips. 1995. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science (Wash. DC). 270:1360-1362.
69. Moskophidis, D., F. Lechner, H. Pircher, and R.M. Zinkernagel. 1993. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (Lond.). 362:758-761.
70. Bour, S., U. Schubert, and K. Strebel. 1995. The human immunodeficiency virus type-1 Vpu protein specifically binds to the cytoplasmic domain of CD4: implications for the mechanism of degradation. J. Virol. 69:1510-1520.
71. Schubert, U., A.F. Ferrer-Montiel, M. Oblatt-Montal, P. Henklein, K. Strebel, and M. Montal. 1996. Identification of an ion channel activity of the Vpu transmembrane domain and its plausible involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett. 398:12-18.
72. Ewart, G.D., T. Sutherland, P.W. Gage, and G.B. Cox. 1996. The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels. J. Virol. 70:7108-7115.
73. Wiertz, E.J.H.J., D. Tortorella, M. Bogyo, J. Yu, W. Mothes, T.R. Jones, T.A. Rapoport, and H.L. Ploegh. 1996. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. Nature (Lond.). 384:432-438.
74. Hiller, M.M., A. Finger, M. Schweiger, and D.H. Wolf. 1996. ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway. Science (Wash. DC). 273: 1725-1728.
75. Willey, R.L., A. Buckler-White, and K. Strebel. 1994. Sequences in the cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein. J. Virol. 68:1207-1212.